Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Physio-Assist is a French medical technology company specializing in the development of innovative solutions for the management of obstructive pulmonary diseases. The company's flagship product, Simeox, is a non-invasive airway clearance device designed to help patients with chronic respiratory conditions like cystic fibrosis and COPD mobilize and evacuate bronchial mucus. By using high-frequency pneumatic vibrations, Simeox changes the rheology of mucus, making it less viscous and easier to expectorate without causing bronchial collapse. The company focuses on improving the quality of life and respiratory function for patients through evidence-based technology. Physio-Assist operates internationally, providing its technology to both clinical settings and for home use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Physio Assist.